batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ASH 2023 preview – Syndax gets an edge on Kura 21 November 2023 Regulators disagree over Keytruda’s gastric cancer nod 17 November 2023 Astra completes its defeat of Roche in AKT 17 November 2023 Bicycle heralds the return of EphA2 16 November 2023 Astellas pays $175m for a cautious Xtandi insurance plan 16 November 2023 Astra’s Pacific expansion plan hits the rocks 14 November 2023 On further review, KRAS inhibitors aren’t alike 13 November 2023 The first Emerald gleams for Astra 9 November 2023 Load More